Aim: To investigate the protective effect of high density lipoprotein 3 (HDL 3 ) on oxidized low density lipoprotein (ox-LDL)-induced apoptosis in RAW264.7 cells. Methods: RAW264.7 cells were exposed to 50 mg/L ox-LDL for various durations up to 48 h, and apoptosis was detected using Hoechst 33258 staining and flow cytometric analysis. Total cholesterol levels were detected by high performance liquid chromatography, cholesterol efflux was determined by Tritium labeling, and the cellular lipid droplets were assayed by oil red O staining. Results: Treatment with 50 mg/L ox-LDL for 12, 24, and 48 h increased the apoptotic rate of RAW264. 7 cells in a time-dependent manner. The peak apoptotic rate (47.7%) was observed after 48 h incubation. HDL 3 at various concentrations (50 mg/L, 100 mg/L, and 200 mg/L) inhibited the ox-LDL (50 mg/L for 48 h)-mediated apoptosis that was accompanied by an increased rate of intracellular cholesterol efflux, and decreased total cholesterol levels in cells in a concentration-dependent manner. Blockage of cholesterol efflux by brefeldin decreased the protective effect of HDL 3 on ox-LDLinduced apoptosis. Increase of the cholesterol efflux effected by another cholesterol acceptor, β-cyclodextrin, led to a dramatic decrease in the apoptotic rate of cells. Conclusion: HDL 3 antagonizes ox-LDL-induced apoptosis in RAW264.7 cells, through reducing the accumulation of toxic cholesterol.
Introduction
Apoptosis is a key event in the progression of advanced atherosclerosis. Apoptosis of foam cells leads to the development of the necrotic core of an atherosclerotic plaque, and reduction of the excretion of cell matrix in the plaque region, which may contribute to plaque instability and the majority of cardiovascular complications [1] [2] [3] [4] . Several lines of evidence strongly suggest that oxidized low density lipoproteins (ox-LDL) cause apoptosis and necrosis of macrophage cells [5, 6] . After they are taken up by scavenger receptor A, ox-LDL inhibit the efflux of cholesterol from cells, resulting in the accumulation of a large amount of cholesterol within them [7] [8] [9] [10] . Accumulating evidence suggests that elevation of cellular cholesterol plays a critical role in the regulation of ox-LDL-mediated cell apoptosis [11] [12] [13] [14] . Thus, accelerating cholesterol efflux or preventing the accumulation of excess cholesterol in cells may inhibit ox-LDL-induced apoptosis, which could provide new perspectives for the prevention and reversal of atherosclerosis.
Having low levels of high density lipoprotein (HDL) cholesterol is an important cardiovascular risk factor. The atheroprotective activity of HDL is often attributed to its unique ability to facilitate the efflux of cholesterol from nonhepatic cells and subsequently deliver to the liver and steroidogenic organs, a process known as reverse cholesterol transport (RCT) [15, 16] . Previous studies have revealed that HDL suppresses tumor necrosis factor α (TNF-α)-mediated apoptosis in cultured human endothelial cells [17] . However, whether HDL has a protective effect against ox-LDL-induced apoptosis of macrophages and whether this effect correlates with RCT has not yet been investigated. β-Cyclodextrins (β-CD) are cyclic oligomers of glucose that have the capacity to sequester cholesterol in their hydrophobic core. Recent studies have shown that β-CD is capable of stimulating efficient cholesterol efflux from cultured human fibroblasts [18] . In addition, brefeldin A (BFA), an antibiotic, has been shown to inhibit HDL-mediated cholesterol efflux from cholesterolenriched cells [19] . The main aim of the present study was to observe whether HDL 3 antagonized ox-LDL-induced apoptosis by promoting cholesterol efflux in RAW264.7 cells.
Materials and methods
Reagents Dulbecco's modified Eagle's medium (DMEM) and fetal bovine serum were purchased from Gibco/BRL (Grand Island, USA). A Hoechst 33258 staining kit was purchased from the Beyotime Institute of Biotechnology (Jiangsu, China). HDL 3 was purchased from Huanan Company (Guangzhou, China). RAW264.7 cells (a murine macrophage cell line) were purchased from the Institute of Biochemistry and Cell Biology (Shanghai Institute for Biological Science, the Chinese Academy of Sciences, Shanghai, China). All reagents were of analytical grade.
Cell culture RAW264.7 cells were maintained in DMEM containing 10% fetal bovine serum in a humidified atmosphere of 5% CO 2 and 95% O 2 . Cells were incubated with 50 mg/L ox-LDL for 48 h and then treated with various concentrations of HDL 3 (50, 100, or 200 mg/L) or BFA (4 µmol/L) or β-CD (10 mmol/L) for 24 h before analysis. Untreated cells were used as controls.
LDL isolation and oxidization LDL was isolated from nonfrozen human plasma according to the method described in our previous report [20] . The remaining sample in the lowdensity fraction after isolation of very low-density lipoproteins was aliquoted into Quickseal tubes (Brown Caskets, Inc Miami, USA). The volume and the density of solution in each tube were adjusted to 35 mL and 1.063 kg/L with 38% NaBr and 0.15 mol/L NaCl, respectively. Tubes were sealed and centrifuged at 129 400×g at a temperature of 8 °C for 20 h. A sample of approximately 5 µL was recovered from supernatant. The isolated LDL was oxidized with CuSO 4 (10 µmol/L) for 18 h at 37 °C. The degree of oxidation of ox-LDL was assessed on the basis of increased mobility in agarose gel (compared with native LDL) and an increased level of thiobarbituric acid-reactive substances.
Flow cytometry Cultured RAW264.7 cells were collected and washed twice with phosphate-buffered saline (PBS). This was followed by fixing with cold 70% ethanol at 4 °C overnight and resuspending the cells in PBS. Cells were incubated with RNase A for 45 min and then stained with 50 mg/mL propidium iodide in the dark at 4 °C for 60 min. The suspension was analyzed with a FACScan flow cytometer (EPICS-XL, Beckman Coulter, Fullerton, USA). The apoptotic rate was determined on the basis of the "sub-G1" peak.
Hoechst 33258 staining Cells were incubated with or without ox-LDL and then harvested. After being fixed with 4% paraformaldehyde for 30 min at 25 °C, the preparations were washed with cold PBS 3 times and exposed to 10 mg/L Hoechst 33258 in the dark at room temperature for 10 min. Stained cells were observed under a fluorescence microscope. The cells with condensed chromatin and shrunken nuclei were counted as apoptotic cells.
High performance liquid chromatography analysis Cells were scraped from the culture flasks into 0.9% NaCl (1 mL per 50 cm 2 flask) and homogenized on ice by sonication for 10 s. After protein concentration was determined by using a BCA kit (Pierce Biotechnology, Inc Rockford, USA), an equal volume of freshly prepared cold (-20 °C) KOH in ethanol (150 g/L) was added to cell lysates, and the mixture was repeatedly vortexed until clear. An equal volume of 3:2 hexaneisopropanol (v/v) was then added. The mixture was vortexed for 5 min, followed by centrifugation at 800×g (15 °C) for 5 min. The extraction procedure was repeated twice. The combined organic phase was transferred to clean tapered glass tubes and thoroughly dried under nitrogen at 40 °C. The tubes were allowed to cool to room temperature. One hundred microliters of isopropanol-acetonitrile 20:80 (v/v) was added. The sample was solubilized in an ultrasound water bath at room temperature for 5 min. After centrifugation at 800×g for 5 min, the samples were introduced into the high performance liquid chromatography (HPLC) device(Agilent 1100, Agilent Technologies, Inc, Palo Alto, USA). Cholesterol was eluted with 1 mL/min of eluent consisting of 20:80 isopropanol-acetonitrile (v:v) and detected by ultraviolet absorption at 206 nm [21] Assessment of cholesterol efflux Cells were treated with [ 
Results
ox-LDL induced apoptosis of RAW264.7 cells Exposure of RAW264.7 cells to 50 mg/L ox-LDL increased the apoptosis rate of cells in a time-dependent manner. The apoptotic rates after 24 h (23.1%) and 48 h (47.7%) treatment were both sign i f i c a n t l y h i g h e r t h a n t h a t i n t h e c o n t r o l (5.14%; Figure 1) .
Effect of HDL 3 on ox-LDL-induced apoptosis in RAW264.7 cells Typical apoptotic morphological changes, such as condensed chromatin and shrunken nuclei, were seen in RAW264.7 cells after the cells were incubated with ox-LDL for 48 h ( Figure 2B ). Co-administration of HDL 3 inhibited these morphological changes ( Figure 2C-2E ) and decreased the apoptotic rate in a concentration-dependent manner (Figure 3) . (Table 1) . Many lipid droplets were seen after ox-LDL treatment ( Figure 4B ). Co-treatment with HDL 3 and ox-LDL increased the rate of cholesterol efflux (Table 1) , and decreased the total cholesterol (Table 1) Effect of BFA and β-CD on apoptosis and cholesterol efflux in RAW264.7 cells Further observations with a blocker (BFA) and an agonist (β-CD) of cholesterol efflux were performed to investigate the relationship between HDL 3 and reverse cholesterol transport. Flow cytometry analysis showed that BFA alone had no effect on cell apoptosis (Table 2) . However, both the inhibition of ox-LDL-induced apoptosis (Table 2 ) and the facilitation of cholesterol efflux ( Figure 5 ) by 100 mg/L HDL 3 were significantly attenuated by BFA. Cholesterol acceptor β-CD decreased the ox-LDL-induced apoptotic rate from 47.7% to 14.2% (Table 2 ) and increased the rate of cholesterol efflux from 5.2% to 36.5% ( Figure 5 ).
Discussion
Apoptosis is a prominent feature of atherosclerotic lesions in humans and experimental animals. It occurs in macrophages, T lymphocytes, and smooth muscle cells of the lesions, and is implicated in the development and progression of the disease. Increasing evidence suggests that apoptosis of foam cells, mostly macrophages that accumulate large quantities of free cholesterol, contribute to the expansion of a lipid core, and the large eccentric lipid core could lead to plaque instability by conferring a mechanical disadvantage on the plaque through redistribution of circumferential stress to the shoulder regions of the plaque, where nearly 60% of plaque ruptures tend to occur [1] [2] [3] [4] . Therefore, inhibition of macrophage apoptosis may prevent the development of atherosclerosis.
Previous studies have shown that large amounts of cholesterol accumulate in macrophages treated with ox-LDL. Such a change in cholesterol leads to the failure of lipid homeostasis [10] . Furthermore, cellular accumulation of excess cholesterol may serve as a trigger for cell death, and promote ongoing inflammation, calcification, thrombosis and plaque rupture, which are the major sequelae of advanced atherosclerosis. HDL has been shown to protect cultured human endothelial cells induced by TNF-α through inhibition of caspase 3 and caspase 9 activity, and cytochrome c release [17, 22] . However, whether HDL could protect mono- cyte-derived macrophage cells against ox-LDL-induced apoptosis has not yet been studied. Our data demonstrate that after incubation with 50 mg/L ox-LDL for 48 h, RAW264.7 cells display the morphological changes that are typically associated with apoptosis, such as condensed chromatin and shrunken nuclei, and up to 47.7% of cells are apoptotic. Treatment with HDL 3 after 48 h pre-incubation with ox-LDL, decreased the apoptotic rate in a dose-dependent manner, and the apoptotic morphological changes were not present.
Cholesterol accumulation plays a critical role in the occurrence of ox-LDL-mediated cell apoptosis. Evidence suggests that accumulation of intracellular free cholesterol can increase Bax expression, increase cholesterol overloading of mitochondria, increase cytochrome c release, activate caspase-9, and lead to macrophage apoptosis [11] [12] [13] [14] . Studies using experimental models of atherosclerosis indicate that the pro-apoptotic effect of ox-LDL can be reversed by lipid lowering interventions [23] . It is thus possible to protect cells from apoptosis by promoting intracellular cholesterol efflux. Efflux of cholesterol from extrahepatic tissue facilitated by HDL is considered to be an important mechanism by which HDL exerts its protective effects in atherosclerosis progression. HDL enhances not only the translocation of cholesterol from intracellular compartments to the plasma membrane, but also cholesterol efflux from the plasma membrane to the extracellular space [24] . Various HDL subclasses are characterized by difference in shape, density, size, charge, and antigenicity. Mature HDL 3 and HDL 2 are generated from their precursors, lipidfree apoA-1 and lipid-poor pre-β 1 -HDL. Small HDL 3 particles have a greater capacity to facilitate the efflux of cholesterol than large HDL 2 because their small size makes it easier to move to the plasma membrane and bind to receptors (SR-B1) and cholesterol transporters (ABCA1). Furthermore, HDL 3 exerts more powerful anti-oxidative effects than HDL 2 [25] [26] [27] [28] [29] . However, whether the protective effect of HDL 3 on ox-LDLinduced apoptosis is mediated via the promotion of cholesterol efflux remains unclear. In line with this notion, we found that HDL 3 dose-dependently increased the rate of cholesterol efflux, and significantly decreased the apoptotic rate of ox-LDL-treated RAW264.7 cells. Interestingly, when BFA, an antibiotic drug, was present at a concentration of 4 µmol/L during incubation of the cells with HDL 3 , the protective effect of HDL 3 on ox-LDL-induced apoptosis was significantly attenuated. It has previously been shown that BFA inhibits HDL-mediated cholesterol efflux from cholesterol-enriched cells by disturbing the translocation of cholesterol from intracellular compartments to the plasma membrane [19] . Consistent with this finding, our data also revealed that BFA treatment decreased the rate of cholesterol efflux, and increased the level of total cholesterol, accompanied by an increase in the apoptotic rate of cells. In contrast, treatment with cholesterol acceptor β-CD, a cholesterol efflux stimulator, suppressed ox-LDL-induced apoptosis. Overall, our results suggest that promoting cholesterol efflux has great potential in the inhibition of ox-LDL-induced apoptosis in RAW264.7 cells.
In conclusion, cholesterol efflux mediates the protective effects of HDL 3 on ox-LDL-induced apoptosis in RAW264.7 cells. This finding provides new evidence that HDL has a functionally protective effect on atherosclerosis and related complications.
